Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
4.740
-0.040 (-0.84%)
Oct 26, 2026, 10:33 AM EDT - Market open
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $29.6 million as of October 26, 2026. It is the 33,953rd most valuable company in the world and the 4,977th biggest in the United States. Its market cap has decreased by 50.32% in one year.
Market Cap
29.60M
Enterprise Value
2.72M
1-Year Change
-50.32%
Global Rank
Country Rank
#4,977 United States
Category
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $29.60M, a decrease of -94.65%. That is a compound annual growth rate of -38.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 29.60M | -48.39% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celularity | 31.73M |
| Evaxion | 31.36M |
| Impact BioMedical | 30.76M |
| Filana Therapeutics | 30.70M |
| Metagenomi Therapeutics | 30.43M |
| Aardvark Therapeutics | 30.42M |
| TransCode Therapeutics | 29.97M |
| BriaCell Therapeutics | 29.79M |